A Novel Founder Mutation in the RNASEL Gene, 471delAAAG, Is Associated with Prostate Cancer in Ashkenazi Jews

HPC1/RNASEL was recently identified as a candidate gene for hereditary prostate cancer. We identified a novel founder frameshift mutation in RNASEL, 471delAAAG, in Ashkenazi Jews. The mutation frequency in the Ashkenazi population, estimated on the basis of the frequency in 150 healthy young women,...

Full description

Saved in:

Bibliographic Details
Main Authors:	Rennert, Hanna, Bercovich, Dani, Hubert, Ayala, Abeliovich, Dvora, Rozovsky, Uri, Bar-Shira, Anat, Soloviov, Sonya, Schreiber, Letizia, Matzkin, Haim, Rennert, Gad, Kadouri, Luna, Peretz, Tamar, Yaron, Yuval, Orr-Urtreger, Avi
Format:	Artigo
Language:	Inglês
Published:	The American Society of Human Genetics 2002
Subjects:	Report
Online Access:	https://ncbi.nlm.nih.gov/pmc/articles/PMC378554/ https://ncbi.nlm.nih.gov/pubmed/12145743
Tags:	Add Tag No Tags, Be the first to tag this record!

A Novel Founder Mutation in the RNASEL Gene, 471delAAAG, Is Associated with Prostate Cancer in Ashkenazi Jews

Similar Items